PARP Inhibitor Biomarkers Market Is Driven By Increasing Prevalence Of Cancer The PARP inhibitor biomarkers market involves the use of biomarkers to detect PARP inhibitors which are a class of targeted therapy approved for the treatment of cancers like ovarian cancer and breast cancer. PARP inhibitors work by blocking an enzyme called poly (ADP-ribose) polymerase or PARP which is involved in DNA repair. When PARP is blocked, DNA damage caused by chemotherapy or radiation...
0 Geteilt
613 Ansichten
0 Bewertungen